Updated results of phase 1 study of DS-8201a in HER2-expressing or -mutated advanced non-small-cell lung cancer Meeting Abstract


Authors: Tsurutani, J.; Park, H.; Doi, T.; Modi, S.; Takahashi, S.; Nakagawa, K.; Krop, I.; Waqar, S.; Yoh, K.; Li, B.; Taira, S.; Jikoh, T.; Singh, J.; Sugihara, M.; Jänne, P.
Abstract Title: Updated results of phase 1 study of DS-8201a in HER2-expressing or -mutated advanced non-small-cell lung cancer
Meeting Title: IASLC 19th World Conference on Lung Cancer
Keywords: her2; nsclc; antibody-drug conjugate
Journal Title: Journal of Thoracic Oncology
Volume: 13
Issue: 10 Suppl.
Meeting Dates: 2018 Sep 23-26
Meeting Location: Toronto, Canada
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2018-10-01
Start Page: S324
Language: English
ACCESSION: WOS:000454014500228
DOI: 10.1016/j.jtho.2018.08.244
PROVIDER: wos
Notes: Meeting Abstract: OA02.07 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Shanu Modi
    265 Modi
  2. Bob Tingkan Li
    278 Li